, An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice, Antivir Ther, vol.4, pp.89-91, 1999.
, Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients, Antivir Ther, vol.4, pp.83-84, 1999.
, Efficacy and safety of ritonavir/indinavir 100/400 twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals, Antivir Ther, vol.8, pp.603-609, 2003.
, Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients, AIDS, vol.18, issue.5, pp.775-779, 2004.
DOI : 10.1097/00002030-200403260-00008
, First line efavirenz versus lopinavir-ritonavir based highly active antiretroviral therapy for naive patients, AIDS, vol.18, pp.2325-2341, 2004.
, Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.190-195, 2005.
DOI : 10.1093/jac/dki172
, Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy The Swiss HIV Cohort Study, AIDS, vol.15, issue.14, pp.1793-1800, 2001.
DOI : 10.1097/00002030-200109280-00008
, Clinical, virologic, and immunologic response to efavirenz or protease inhibitor based higly active antiretroviral therapy in a cohort of antiretroviral?naive patients with advanced HIV infection (EfaVIP 2 Study), JAIDS, vol.35, pp.343-350, 2004.
, Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, AIDS, vol.16, issue.1, pp.53-61, 2002.
DOI : 10.1097/00002030-200201040-00008
, Comparison of nevirapine and efavirenz containing antiretroviral regimens in antiretroviral-naive patients: a cohort study, HIV Clin Trials, vol.3, pp.296-303, 2002.
, Virologic and immunologic response to regimens containing nevirapine or efavirenz
, Efavirenz versus neverapine in current clinical practice: a prospective, open-label observational study, JAIDS, vol.35, pp.492-502, 2004.
, Comparison of efavirenz and nevirapine in HIV-infected patients (NEEF Cohort), International Journal of STD & AIDS, vol.16, issue.6, pp.404-409, 2005.
DOI : 10.1258/0956462054094060
, Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naive patients with advanced HIV infection, HIV Medicine, vol.124, issue.1, pp.105-109, 2004.
DOI : 10.1097/00002030-200009290-00012
, Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection, New England Journal of Medicine, vol.350, issue.18, pp.1850-1861, 2004.
DOI : 10.1056/NEJMoa031772
, Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults, New England Journal of Medicine, vol.341, issue.25, pp.1865-1873, 1999.
DOI : 10.1056/NEJM199912163412501
, Immunological reconstitution in severely immunosuppressed antiretroviral-naive patients (<100 CD4 + T cells/mm 3 ) using a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a boosted protease inhibitor (PI)-based antiretroviral therapy regimen: 96-week results (the Advanz Trial). 10th European AIDS Conference, pp.17-20, 2005.
, Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open?label randomized trial, Lancet, vol.368, pp.287-298, 2006.
, Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study, The Lancet, vol.363, issue.9417, pp.1253-1263, 2004.
DOI : 10.1016/S0140-6736(04)15997-7
, Efficacy and safety of nevirapine versus efavirenz when combined in ART regimens in HIV infected antiretroviral-naïve persons (the NNRTI substudy of FIRST-CPCRA 058) ? ACTG 5142. XVI International AIDS Conference, pp.13-18, 2006.
, A prospective randomized, phase III trial of NRTI, PI, and NNRTI sparing regimens for initial treatment of HIV-1 infection ? ACTG 5142. XVI International AIDS Conference, pp.13-18, 2006.
, Response to higly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection, JAIDS, vol.39, pp.284-292, 2005.
, The central role of the propensity score in observational studies for causal effects, Biometrika, vol.70, issue.1, pp.41-55, 1983.
DOI : 10.1093/biomet/70.1.41
, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Statistics in Medicine, vol.17, issue.19, pp.2265-2281, 1998.
DOI : 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
, Using propensity scores to adjust for group differences: examples comparing alternative surgical methods. 25th Annual SAS Users Group International Conference, 2000.
, Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection, New England Journal of Medicine, vol.349, issue.24, pp.2293-2303, 2003.
DOI : 10.1056/NEJMoa030264
, Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV, AIDS, vol.18, issue.15, pp.2029-2038, 2004.
DOI : 10.1097/00002030-200410210-00007
, Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials, AIDS, vol.13, issue.15, pp.2075-2082, 1999.
DOI : 10.1097/00002030-199910220-00010